Syk: A Novel Target for Treatment of Inflammation in Lung Disease

E-ISSN： 2212-4055|8|2|87-95

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.8, Iss.2, 2009-06, pp. : 87-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spleen tyrosine kinase (Syk) as a novel target for allergic asthma and rhinitis

By Ulanova Marina Duta Florentina Puttagunta Lakshmi Schreiber Alan D Befus A Dean

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 901-921

Informa Healthcare

Access to resources Recommend Favorite

Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease

By Cazzola Mario Ciaprini Chiara Page Clive P Matera Maria G

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 10, 2007-10 ,pp. : 1273-1286

Informa Healthcare

Access to resources Recommend Favorite

Death receptor-mediated suicide: a novel target of autoimmune disease treatment

By Brunner T. Arnold D. Wasem C. Laissue J.A. Mueller C.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 9, 1999-09 ,pp. : 1359-1372

Informa Healthcare

Access to resources Recommend Favorite

Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis

Current Pharmaceutical Design, Vol. 23, Iss. 8, 2017-04 ,pp. : 1216-1227

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammation as a Therapeutic Target in Acute Ischemic Stroke Treatment

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 14, 2009-10 ,pp. : 1240-1260

Bentham Science Publishers

Access to resources Recommend Favorite